Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -262.12% | 246.02% | 84.34% | -262.57% | 248.36% |
| Total Depreciation and Amortization | 15.79% | -10.73% | -10.76% | -4.12% | -23.15% |
| Total Amortization of Deferred Charges | 27.09% | 0.53% | -19.72% | -5.72% | 24.25% |
| Total Other Non-Cash Items | 291.19% | -785.71% | -95.38% | 228.02% | -290.57% |
| Change in Net Operating Assets | -67.09% | -13.62% | 118.50% | 503.41% | -31.66% |
| Cash from Operations | 63.25% | 16.15% | 287.59% | 175.49% | -426.27% |
| Capital Expenditure | -41.64% | -12.40% | -101.60% | -44.41% | -192.02% |
| Sale of Property, Plant, and Equipment | 71.61% | 493.80% | -84.56% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.84% | 99.50% | -- | 100.00% | -12,490.00% |
| Cash from Investing | -41.46% | -7.46% | -112.66% | -34.37% | -209.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -68.46% | -18.83% | 98.30% | -619.89% | 67.28% |
| Issuance of Common Stock | -98.43% | 362.81% | 206.59% | 36.84% | -91.05% |
| Repurchase of Common Stock | 17.48% | -346.68% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,554.25% | -309.62% | 83.24% | -656.84% | -100.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 687.48% | -11.07% | -8.96% | 15.10% | -123.71% |